GI Signals · Trends

The digest, over time.

Charts from the 16 published issues so far: how selective it stays, which areas are busy, and what moves the standard of care.

01 / OVER TIME

How selective it stays

Papers surfaced as a share of papers screened, each week (oldest first). It should stay low and steady.

0%10%20%30%40%50%Surfaced %7%06/24/269%16%07/19/2637%31%08/02/2634%28%08/16/2629%33%08/30/2633%31%09/13/2638%29%09/27/2636%42%10/11/2630%10/18/26
02 / OVER TIME

Which areas are busy

Surfaced papers by subspecialty, week by week (oldest at left). A busy section or a quiet stretch shows up week to week.

06/24/26
07/12/26
07/19/26
07/26/26
08/02/26
08/09/26
08/16/26
08/23/26
08/30/26
09/06/26
09/13/26
09/20/26
09/27/26
10/04/26
10/11/26
10/18/26
IBD
5
1
5
6
19
9
5
11
6
24
9
6
9
21
13
5
Hepatology
2
5
4
12
36
14
9
6
15
30
16
18
15
38
20
10
Esophagus/Reflux
2
2
2
4
5
1
6
5
3
3
2
8
4
6
Pancreas/Biliary
3
2
5
2
11
5
3
6
5
10
3
6
4
9
5
4
Endoscopy
5
5
4
21
18
16
8
8
13
15
10
13
8
10
14
7
Motility
4
5
7
9
3
3
5
2
6
1
1
6
4
6
5
Colorectal
5
2
1
3
9
5
2
3
9
1
2
6
6
10
7
Nutrition
3
2
3
2
3
2
2
2
1
2
3
03 / OVER TIME

How much each week shifts the standard

Mean standard-shift by week, oldest first (1 reinforces current practice, 5 challenges it). A busy week reads differently from a quiet one.

12345Mean shift3.306/24/262.12.607/19/261.91.508/02/262.12.108/16/262.31.508/30/261.62.509/13/261.81.709/27/261.61.610/11/261.610/18/26
04 / OVER TIME

Which journals show up most

Cumulative surfaced papers by journal: the journals that carry the signal, week after week.

Inflamm Bowel Dis69
Clin Gastro Hep64
Gut54
Liver International52
Dig Dis Sci50
J Gastro Hep47
Aliment Pharm Ther41
Dig Liver Dis40
05 / OVER TIME

The run so far

One tile per week (oldest first): how many papers surfaced and the spread of their signal scores.

06/24/26 · #1
29surfaced
score 7 to 92
07/12/26 · #2
17surfaced
score 32 to 80
07/19/26 · #3
28surfaced
score 37 to 83
07/26/26 · #4
58surfaced
score 32 to 80
08/02/26 · #5
107surfaced
score 35 to 87
08/09/26 · #6
52surfaced
score 32 to 79
08/16/26 · #7
28surfaced
score 16 to 79
08/23/26 · #8
41surfaced
score 40 to 88
08/30/26 · #9
53surfaced
score 38 to 95
09/06/26 · #10
101surfaced
score 36 to 89
09/13/26 · #11
45surfaced
score 37 to 92
09/20/26 · #12
51surfaced
score 37 to 86
09/27/26 · #13
50surfaced
score 36 to 82
10/04/26 · #14
97surfaced
score 35 to 88
10/11/26 · #15
74surfaced
score 36 to 91
10/18/26 · #16
47surfaced
score 38 to 88
06 / THIS ISSUE

The signal map

Every surfaced paper placed by evidence strength and clinical utility; dot size is the journal's impact factor, and a dark ring marks a paper that refines or changes its standard. Top right is the week's must-read.

306089narrative reviewmeta-analysis →Clinical utilityEvidence strength
07 / THIS ISSUE

What drove each score

The top papers, each split into the four scoring parts, so you can see why a paper ranked without opening its card.

14-Day Keverprazan-Amoxicillin Dual Therapy Versus Bismuth-Containing Quadruple Therapy as First-Line Treatment for Helicobacter pylori Eradication: A Prospective, Single-Center, Randomized Controlled Trial.88
Serrated polyp detection rates beyond adenoma detection rate for postcolonoscopy colorectal cancer: findings from the SCREESCO trial.83
Phase 2 Trial of Icotrokinra for Patients with Ulcerative Colitis.74
Optimal Incidence Threshold for Cost-Effective Hepatocellular Carcinoma Surveillance in Alcohol-Associated Cirrhosis.74
Abnormal left ventricular mass as a prognostic marker for outcomes in infants and children with cirrhosis.76
Evaluation of Extrahepatic Bile Duct Resection as a Parenchyma-Preserving Alternative in Bismuth I-II Perihilar Cholangiocarcinoma: A Comparative Single-Center Analysis.67
Papillary Balloon Dilation Versus Sphincterotomy for Small Common Bile Duct Stones: Recurrence and Pneumobilia in a Retrospective Cohort.67
Diffuse esophageal eosinophilia is associated with increased endoscopic severity and topical steroid non-response in patients with eosinophilic esophagitis.66
Oncologic Outcomes and Adjuvant Chemotherapy Use in Early- Versus Late-Onset Colon Cancer: A Propensity Score-Matched Analysis.72
Clinical Course and Predictors of Biologic Therapy, Hospitalisation and Surgery: A Five-Year Prospective Study in Newly Diagnosed Inflammatory Bowel Disease.70
The New Face of an Old Disease: A Survey of Young People regarding Early-Onset Colorectal Cancer.70
Duodenal involvement in MUTYH-associated polyposis: findings from an international study and implications for endoscopic surveillance.64
Study rigorShiftPractice relevanceJournal standing